The DOI matches its Crossref record; 11 of the 11 references it cites were found in a registry or an index.
Persistent Postwithdrawal Disorders Induced by Paroxetine, a Selective Serotonin Reuptake Inhibitor, and Treated with Specific Cognitive Behavioral Therapy
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Another study (Belaise et al., 2014) was a case series of three patients referred to a CBT service for the treatment of PAWS after discontinuation of paroxetine”
From Post-acute withdrawal syndrome (PAWS) after stopping antidepressants: a systematic review with meta-narrative synthesis (2025) · cites this paper as Belaise et al., 2014
In the citing paper
“A case series of three patients who discontinued paroxetine (Belaise et al., 2014) reported that remission of PAWS was achieved between 3 and 5 months after the patients began treatment with cognitive-behavioural therapy (CBT).”
From Post-acute withdrawal syndrome (PAWS) after stopping antidepressants: a systematic review with meta-narrative synthesis (2025) · cites this paper as Belaise et al., 2014
In the citing paper
“A protocol based on the sequential combination of CBT and WBT in post-withdrawal disorders has been devised 101 and tested in case reports 102 .”
From The pursuit of euthymia (2020) · cites this paper as [102]
In the citing paper
“The authors reported only ADDS symptoms that occurred in more than 10% of patients, showing no differences between those who received sertraline compared to venlafaxine XR.”
From Withdrawal Symptoms after Selective Serotonin Reuptake Inhibitor Discontinuation: A Systematic Review (2015) · cites this paper as [42]
In the citing paper
“Subjects taking venlafaxine XR also reported discontinuation symptoms from minimal to very severe (minimal = 17.7%; mild = 27.4%;moderate = 38.7%;severe = 3.2%; very severe = 1.6%).”
From Withdrawal Symptoms after Selective Serotonin Reuptake Inhibitor Discontinuation: A Systematic Review (2015) · cites this paper as [42]
4 more claims about this paper
Create a free account to see every claim other papers make about this one.
Citations
Cites
Selective serotonin reuptake inhibitor discontinuation syndrome: a randomized clinical trial
Rosenbaum, J. F., Fava, M., Hoog, S. L., Ascroft, R. C., & Krebs, W. B. (1998) · Biological Psychiatry · doi:10.1016/s0006-3223(98)00126-7 · Cited by 574
Chouinard, G., & Chouinard, V.-A. (2008) · Psychotherapy and Psychosomatics · doi:10.1159/000112883 · Cited by 168
Self-citationThe mechanisms of tolerance in antidepressant action
Fava, G. A., & Offidani, E. (2011) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2010.07.026 · Cited by 158
Fava, G. A., Rafanelli, C., Tomba, E., Guidi, J., & Grandi, S. (2011) · Psychotherapy and Psychosomatics · doi:10.1159/000321575 · Cited by 156
The Clinical Interview for Depression: A Comprehensive Review of Studies and Clinimetric Properties
Guidi, J., Fava, G. A., Bech, P., & Paykel, E. S. (2010) · Psychotherapy and Psychosomatics · doi:10.1159/000317532 · Cited by 91
Explanatory Therapy in Hypochondriasis
Fava, G. A., Grandi, S., Rafanelli, C., Fabbri, S., & Cazzaro, M. (2000) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v61n0414 · Cited by 73
Belaise, C., Gatti, A., Chouinard, V.-A., & Chouinard, G. (2012) · Psychotherapy and Psychosomatics · doi:10.1159/000341178 · Cited by 45
Self-citation(2006) · PubMed · Cited by 33
Self-citationScholten, W., Batelaan, N. M., van Oppen, P., Smit, J. H., & van Balkom, A. J. L. M. (2013) · Psychotherapy and Psychosomatics · doi:10.1159/000350450 · Cited by 12
Selective Serotonin Reuptake Inhibitor Discontinuation Syndrome
Finfgeld, D. L. (2002) · Journal of Psychosocial Nursing and Mental Health Services · doi:10.3928/0279-3695-20021201-10 · Cited by 10
Cited by
Carvalho, A. F., Sharma, M. S., Brunoni, A. R., Vieta, E., & Fava, G. A. (2016) · Psychotherapy and Psychosomatics · doi:10.1159/000447034 · Cited by 650
Fava, G. A., Gatti, A., Belaise, C., Guidi, J., & Offidani, E. (2015) · Psychotherapy and Psychosomatics · doi:10.1159/000370338 · Cited by 436
Self-citationDavies, J., & Read, J. (2019) · Addictive Behaviors · doi:10.1016/j.addbeh.2018.08.027 · Cited by 387
“…U.K. and U.S.A. withdrawal guidelines in that they found that a significant proportion of people experiencing withdrawal do so for more than 2 weeks (Belaise et al., 2014; Davies et al., 2018b; Fava et al., 2007; Narayan & Haddad, 2010; Stockmann et al., 2018; RCPsych, 2012; Zajecka et al., 1998).”
BackgroundAntidepressant discontinuation reactions: Are preventable and simple to treat
Haddad, P., Lejoyeux, M., & Young, A. (1998) · BMJ · doi:10.1136/bmj.316.7138.1105 · Cited by 286
Tapering of SSRI treatment to mitigate withdrawal symptoms
Horowitz, M. A., & Taylor, D. (2019) · The Lancet Psychiatry · doi:10.1016/s2215-0366(19)30032-x · Cited by 280
Antipsychotic-Induced Dopamine Supersensitivity Psychosis: Pharmacology, Criteria, and Therapy
Chouinard, G., Samaha, A.-N., Chouinard, V.-A., Peretti, C.-S., Kanahara, N., Takase, M., & Iyo, M. (2017) · Psychotherapy and Psychosomatics · doi:10.1159/000477313 · Cited by 270
Self-citationAcute and Persistent Withdrawal Syndromes Following Discontinuation of Psychotropic Medications
Cosci, F., & Chouinard, G. (2020) · Psychotherapy and Psychosomatics · doi:10.1159/000506868 · Cited by 265
Self-citationGuidi, J., Tomba, E., & Fava, G. A. (2016) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2015.15040476 · Cited by 167
New Classification of Selective Serotonin Reuptake Inhibitor Withdrawal
Chouinard, G., & Chouinard, V.-A. (2015) · Psychotherapy and Psychosomatics · doi:10.1159/000371865 · Cited by 164
Self-citationFava, G. A., & Guidi, J. (2020) · World Psychiatry · doi:10.1002/wps.20698 · Cited by 148
Antidepressant Withdrawal and Rebound Phenomena
Henssler, J., Heinz, A., Brandt, L., & Bschor, T. (2019) · Deutsches Ärzteblatt international · doi:10.3238/arztebl.2019.0355 · Cited by 50
Rational Use of Antidepressant Drugs
Fava, G. A. (2014) · Psychotherapy and Psychosomatics · doi:10.1159/000362803 · Cited by 95
Well-Being Therapy: Current Indications and Emerging Perspectives
Fava, G. A. (2016) · Psychotherapy and Psychosomatics · doi:10.1159/000444114 · Cited by 96
Fava, G. A., Cosci, F., Guidi, J., & Tomba, E. (2017) · Depression and Anxiety · doi:10.1002/da.22629 · Cited by 95
Lerner, A., & Klein, M. (2019) · Brain Communications · doi:10.1093/braincomms/fcz025 · Cited by 89
The clinical role of well-being therapy
Guidi, J., Rafanelli, C., & Fava, G. A. (2018) · Nordic Journal of Psychiatry · doi:10.1080/08039488.2018.1492013 · Cited by 85
“A protocol based on the sequential combination of CBT and WBT has been devised and tested in case reports [50].”
MethodDiscontinuing Antidepressant Drugs: Lesson from a Failed Trial and Extensive Clinical Experience
Fava, G. A., & Belaise, C. (2018) · Psychotherapy and Psychosomatics · doi:10.1159/000492693 · Cited by 77
Self-citationNordahl, H. M., Vogel, P. A., Morken, G., Stiles, T. C., Sandvik, P., & Adrian Wells, A. (2016) · Psychotherapy and Psychosomatics · doi:10.1159/000447013 · Cited by 65
Behavioral Toxicity Revisited: Iatrogenic Comorbidity in Psychiatric Evaluation and Treatment
Fava, G. A., Cosci, F., Offidani, E., & Guidi, J. (2016) · Journal of Clinical Psychopharmacology · doi:10.1097/jcp.0000000000000570 · Cited by 55
“Untreated symptoms may be mild and resolve spontaneously in 1 to 3 weeks; in other cases, they may persist for months or even years, leading towhat has been defined as persistent postwithdrawal disorder.(18) Withdrawal symptoms are likely to be misunderstood as indicators of impending relapse and may lead to reinstitu…”
BackgroundThe emerging role of euthymia in psychotherapy research and practice
Guidi, J., & Fava, G. A. (2020) · Clinical Psychology Review · doi:10.1016/j.cpr.2020.101941 · Cited by 40
Scholten, W. D., Batelaan, N. M., van Oppen, P., Smit, J. H., Hoogendoorn, A. W., van Megen, H. J. G. M., Cath, D. C., & van Balkom, A. J. L. M. (2018) · Psychotherapy and Psychosomatics · doi:10.1159/000489498 · Cited by 33
Cosci, F., & Chouinard, G. (2019) · Neurobiology of Depression · doi:10.1016/b978-0-12-813333-0.00007-x · Cited by 29
Self-citationConceptual and Clinical Innovations of Well-being Therapy
Guidi, J., & Fava, G. A. (2021) · International Journal of Cognitive Therapy · doi:10.1007/s41811-021-00101-1 · Cited by 30
Pannu, A. S., & Goyal, R. K. (2024) · Current Drug Safety · doi:10.2174/0115748863301630240417071353 · Cited by 29
Predictors of successful discontinuation of antipsychotics and antidepressants
Lincoln, T. M., Sommer, D., Quazzola, M., Witzgall, T., & Schlier, B. (2021) · Psychological Medicine · doi:10.1017/s0033291721005146 · Cited by 13
SSRI withdrawal syndrome in children and adolescents: a narrative literature review
Khan, Y. S., Khoodoruth, M. A. S., Albobali, Y., & Haddad, P. M. (2023) · Expert Opinion on Drug Safety · doi:10.1080/14740338.2023.2224557 · Cited by 12
“Prospective studies may prioritize exploring non-pharmacological interventions, such as cognitive-behavioral therapy, to mitigate SSRI discontinuation symptoms in the pediatric population [43,44].”
BackgroundCocaine Use Disorder Treated with Specific Cognitive Behavioral Therapy and Adjunctive Propranolol
Chopin, M.-V., Peretti, C.-S., Gisquet-Verrier, P., Hoffmann, C. P., Belaïd, A., & Chouinard, G. (2015) · Psychotherapy and Psychosomatics · doi:10.1159/000441036 · Cited by 11
Self-citationCosci, F. (2017) · Personalized Medicine in Psychiatry · doi:10.1016/j.pmip.2016.11.001 · Cited by 8
Rennwald, A., & Hengartner, M. P. (2025) · Epidemiology and Psychiatric Sciences · doi:10.1017/s204579602500023x · Cited by 8
“A case series of three patients who discontinued paroxetine (Belaise et al. , 2014) reported that remission of PAWS was achieved between 3 and 5 months after the patients began treatment with cognitive-behavioural therapy (CBT).”
Well-being Therapy in Depressive Disorders
Mansueto, G., & Cosci, F. (2021) · Advances in experimental medicine and biology · doi:10.1007/978-981-33-6044-0_19 · Cited by 8
Well-Being Therapy in Anxiety Disorders
Cosci, F. (2020) · Advances in experimental medicine and biology · doi:10.1007/978-981-32-9705-0_24 · Cited by 5
Smithson, J., & Mitchell, P. B. (2019) · Side effects of drugs annual · doi:10.1016/bs.seda.2019.10.002 · Cited by 6
Fava, G. A., Cosci, F., Montiel, C. B., & Tomba, E. (2019) · Psychotherapy and Psychosomatics · doi:10.1159/000495967 · Cited by 4
An Editor’s Journey Ends, but the Journal’s Mission Continues
Fava, G. A. (2022) · Psychotherapy and Psychosomatics · doi:10.1159/000524654 · Cited by 5
Staging of Panic Disorder: Implications for Neurobiology and Treatment
Cosci, F. (2016) · Springer eBooks · doi:10.1007/978-3-319-12538-1_5 · Cited by 1
New Applications of Well-Being Therapy
Benasi, G., Guidi, J., Rafanelli, C., & Fava, G. A. (2019) · RIVISTA SPERIMENTALE DI FRENIATRIA · doi:10.3280/rsf2019-001006 · Cited by 1
Fava, G. A., & Guidi, J. (2020) · Ärztliche Psychotherapie · doi:10.21706/aep-15-3-149 · Cited by 1
Fava, G. A. (2018) · Elsevier eBooks · doi:10.1016/b978-2-294-76050-1.00017-9
Psychotherapeutic interventions
Cosci, F., & Fava, G. A. (2017) · Oxford University Press eBooks · doi:10.1093/med/9780198746638.003.0018
(2014) · Reactions Weekly · doi:10.1007/s40278-014-3940-5
Fava, G. A. (2018) · Elsevier eBooks · doi:10.1016/b978-2-294-76050-1.00014-3
Pharmakotherapie bei Angststörungen – eine kritische Auseinandersetzung
Chrysanthou, S., & Köllner, V. (2022) · PiD - Psychotherapie im Dialog · doi:10.1055/a-1686-2054
Well-Being Therapy for Depression
Romanazzo, S., & Cosci, F. (2024) · Advances in experimental medicine and biology · doi:10.1007/978-981-97-4402-2_14
Les manifestations cliniques du sevrage après arrêt des antidépresseurs
Fava, G. A., & Peretti, C.-S. (2024) · Elsevier eBooks · doi:10.1016/b978-2-294-77932-9.00002-9
Stratégies et options pharmacologiques
Fava, G. A., & Peretti, C.-S. (2024) · Elsevier eBooks · doi:10.1016/b978-2-294-77932-9.00008-x
Metadata
- Authors
- Belaise, C., Gatti, A., Chouinard, V.-A., & Chouinard, G.
- Affiliations
- University of Bologna (IT)
- Harvard University (US)
- McGill University (CA)
- Venue
- Psychotherapy and Psychosomatics
- Publisher
- S. Karger AG
- Published
- 2014
- Volume
- 83
- Issue
- 4
- Pages
- 247-248
- ISSN
- 0033-3190 (ISSN-L)
- 1423-0348
- OpenAlex
- W2041187061
- Cited by
- 44
- References
- 11
- Citations by year
- 2025: 1 · 2024: 4 · 2023: 1 · 2022: 2 · 2021: 3 · 2020: 5 · 2019: 6 · 2018: 6 · 2017: 3 · 2016: 6 · 2015: 4 · 2014: 2
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.karger.com/Services/SiteLicenses (vor)
- www.karger.com/Services/SiteLicenses (tdm)
- Locations
- Psychotherapy and Psychosomatics (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Pharmacology (medical) › Treatment of Major Depression
- Health Sciences › Medicine › Psychiatry and Mental health › Electroconvulsive Therapy Studies
- Social Sciences › Psychology › Experimental and Cognitive Psychology › Anxiety, Depression, Psychometrics, Treatment, Cognitive Processes
- Keywords
- paroxetine, selective serotonin reuptake inhibitors, antidepressant discontinuation, cognitive behavioral therapy, SSRI adverse effects
- MeSH terms
- Antidepressive Agents, Anxiety Disorders, Humans, Cognitive Behavioral Therapy
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.